Difficulty: Medium
Average Score: 86%
Practice
Maximal medical therapy for treating angina pectoris is represented by which of the following choices?
Correct answer
D
Rationale
In the context of managing angina pectoris, maximal medical therapy aims to address the underlying mechanisms contributing to myocardial ischemia. The correct answer, option D (Isosorbide, atenolol, diltiazem), represents a comprehensive approach targeting different aspects of angina treatment.
Isosorbide is a nitrate that dilates coronary arteries, reducing myocardial oxygen demand. Atenolol, a beta-blocker, decreases heart rate and contractility, reducing myocardial workload. Diltiazem, a calcium channel blocker, dilates coronary arteries and reduces myocardial oxygen demand by decreasing contractility and heart rate.
Option A (Diltiazem, verapamil, nitroglycerin) includes two calcium channel blockers which, when combined, can lead to excessive vasodilation and negative inotropic effects. Nitroglycerin provides acute relief but is not part of maximal long-term therapy.
Option B (Atenolol, isoproterenol, diltiazem) includes an inappropriate use of isoproterenol, a non-selective beta-agonist, which can worsen angina due to increased myocardial oxygen demand.
Option C (Verapamil, nifedipine, propranolol) combines two calcium channel blockers with a beta-blocker, which can lead to excessive negative inotropic effects and bradycardia, potentially worsening angina symptoms.
Educationally, understanding the rationale behind maximal medical therapy for angina helps students appreciate the multifactorial approach needed to effectively manage this condition. It underscores the importance of balancing oxygen supply and demand in the ischemic heart to alleviate symptoms and improve patient outcomes.
Isosorbide is a nitrate that dilates coronary arteries, reducing myocardial oxygen demand. Atenolol, a beta-blocker, decreases heart rate and contractility, reducing myocardial workload. Diltiazem, a calcium channel blocker, dilates coronary arteries and reduces myocardial oxygen demand by decreasing contractility and heart rate.
Option A (Diltiazem, verapamil, nitroglycerin) includes two calcium channel blockers which, when combined, can lead to excessive vasodilation and negative inotropic effects. Nitroglycerin provides acute relief but is not part of maximal long-term therapy.
Option B (Atenolol, isoproterenol, diltiazem) includes an inappropriate use of isoproterenol, a non-selective beta-agonist, which can worsen angina due to increased myocardial oxygen demand.
Option C (Verapamil, nifedipine, propranolol) combines two calcium channel blockers with a beta-blocker, which can lead to excessive negative inotropic effects and bradycardia, potentially worsening angina symptoms.
Educationally, understanding the rationale behind maximal medical therapy for angina helps students appreciate the multifactorial approach needed to effectively manage this condition. It underscores the importance of balancing oxygen supply and demand in the ischemic heart to alleviate symptoms and improve patient outcomes.